According to our latest report, entitled “US Stem Cell Market Analysis”, the US is one of the major stem cell markets in the world, and the country has been witnessing a significant level of positive development over the past few years. The market has been well supported by factors, such as huge investment, strong demand, and rising disease incidences.
Though at its nascent stage, adult stem cells products market is booming at a fast pace. Adult stem cell are being widely used in therapy and research purposes, as there are no ethical and legal issues involved with its use. New products in different areas (such as cardiovascular, lung disorders, and diabetes) are therefore, expected to enter the market by the end of 2013, and drive the market of adult stem cell product further to reach around US$ 615 Million, growing at a CAGR of 37.8% during 2010-2013.
The report, “US Stem Cell Market Analysis”, provides an effective analysis and depiction of the US stem cell market, making use of reliable statistics and proper content flow. The report illustrates the current market trends and their impact on the future industry performance. It also investigates several clinical trials in the country that are making use of stem cells for the development of advanced treatments. The research is intended to facilitate consultants, industry analysts, and vendors to obtain an in-depth knowledge of the current, past, and future performance of the industry. It provides an extensive analysis of the recent trends of the US stem cell market along with impartial analysis considering the impact of financial crisis on its performance. Overall, the report offers a comprehensive analysis of the entire stem cell market in the US.
For more information visit: http://www.rncos.com/Report/IM191.htm |
